TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer.
Keith L Knutson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.